---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-032762"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2026-10-16T13:29:32+00:00"
generated_at: "2026-10-16T13:30:03.976581+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Moleculin Biotech furnishes Oct 16, 2026 investor presentation under Reg FD; exhibit text not included

## Summary
- Moleculin Biotech (MBRX) disclosed a corporate investor presentation dated October 16, 2026 as Exhibit 99.1 under Item 7.01 Regulation FD.
- Filing states the presentation is posted on the Company's website, but the exhibit supplied contains no readable content beyond the 'Exhibit 99.1' header.
- No financial results, clinical trial data, guidance, or transaction terms appear anywhere in the filing body; no specific facts can be extracted.
- Signed by Jonathan P. Foster on October 16, 2026; company address listed as 5300 Memorial Drive, Suite 950, Houston, TX 77007.

## SEC filing metadata
- accession: 0001437749-26-032762
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2026-10-16T13:29:32+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774926032762/0001437749-26-032762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774926032762/mbrx20261015_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-032762
- JSON: https://secwatch.observer/filing/0001437749-26-032762.json
- Plain text: https://secwatch.observer/filing/0001437749-26-032762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.